KALA BIO, Inc. (KALA)
2025-06-30 | ||||
---|---|---|---|---|
Research and development | 6,232 | |||
General and administrative | 4,643 | |||
Loss (gain) on fair value remeasurement of contingent consideration | -153 | |||
Total costs and expenses | 11,028 | |||
Loss from operations | -11,028 | |||
Interest income | 407 | |||
Interest expense | 1,081 | |||
Grant income | 547 | |||
Total other income (expense) | -127 | |||
Net loss | -11,155 | |||
Earnings per share, basic | -1.71 | |||
Earnings per share, diluted | -1.71 | |||
Weighted average number of shares outstanding, basic | 6,513,108 | |||
Weighted average number of shares outstanding, diluted | 6,513,108 |